Navigation Links
FDA Collaboration to Monitor Rare Eye Condition Associated With Cataract Surgery
Date:12/20/2011

SILVER SPRING, Md., Dec. 20, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration and other government and professional organizations today unveiled a program to monitor medical devices used in cataract surgery in an effort to stem outbreaks of a rare, inflammatory condition associated with the procedure.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

The Proactive TASS Program (PTP) is designed to reveal outbreaks of Toxic Anterior Segment Syndrome (TASS) early with the goal of minimizing the number of people affected.

Outbreaks of TASS over the past 11 years have affected patients from hundreds of surgical centers in North America. In some cases, the FDA traced the cause to contaminated products used during anterior segment surgery, resulting in recalls of several different ophthalmic devices. In other cases investigators were unable to determine the cause.

Researchers in FDA's Center for Devices and Radiological Health (CDRH) conducted studies to confirm the causes of TASS and were able to develop new testing methods to determine what role medical devices may play in the development of the condition .  

Specifically, research findings confirmed the level of certain contaminants that lead to inflammation and the best methods for testing at specific contaminant levels. This information can be used by ophthalmic device manufacturers to improve the safety of their devices and help to prevent TASS outbreaks from happening.

The program is a collaboration between the FDA, Centers for Disease Control and Prevention (CDC), and the American Academy of Ophthalmology (AAO), and is one of the first surveillance programs in the United States to monitor the medical devices used in cataract surgery and to aid in early identification of a national TASS outbreak.

"As the baby boomers continue to age, the number of cataract surgerie
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Carolinas HealthCare System and MinuteClinic Enter Into Clinical Collaboration
2. Heska Announces Exploration of New Technologies Through Strategic Collaboration with Entegrion, Inc.
3. Multiple Myeloma Research Foundation (MMRF) and Onyx Pharmaceuticals Announce Multi-Year Collaboration to Accelerate Personalized Medicine Approaches for Multiple Myeloma
4. Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen
5. AirStrip Technologies Announces Home Health Collaboration With Qualcomm Life
6. Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension
7. Russian Institute of Nutrition-Nutrilite Health Institute Collaboration Identifies Stress Markers Potentially Linked to Chronic Diseases in Overweight Russian Adults
8. Cancer Support Community in Collaboration with the Center for Breast Health at Washington Hospital Center Hosts Free Frankly Speaking About Cancer: Spotlight on Breast Reconstruction Workshop on Thursday, November 10
9. Virginia G. Piper Cancer Center & TGen Form Drug Development Collaboration With Cedars-Sinai
10. Quanticel Pharmaceuticals Enters Into Strategic Cancer Drug Discovery Collaboration With Celgene Corporation
11. JDRF and the Helmsley Charitable Trust Form a Collaboration to Accelerate Innovative Type 1 Diabetes Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... MENLO PARK, Calif. , May ... (OTCQX: DMPI) ("DelMar" and the "Company"), a ... cancer therapies in new orphan drug indications, presented ... of Cancer Research (AACR) Advances in Brain Cancer ... lead product candidate VAL-083 (dianhydrogalactitol) to ...
(Date:5/29/2015)...  Eli Lilly and Company (NYSE: LLY ) ... they have entered into a clinical trial collaboration to ... anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with CYRAMZA ... medicine. The planned study will assess the combination as ... The Phase I study is expected to establish ...
(Date:5/29/2015)...  World-renowned prostate surgeon and New York Urologist, Dr. ... MR/Ultrasound Fusion-Guided Biopsy for detecting aggressive prostate ... at Lenox Hill Hospital is the only center using ... New York City . We,ve seen tremendous improvement in ... use of an MRI makes for a much more accurate ...
Breaking Medicine Technology:DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
... Nov. 14 The American Legion,welcomes the findings of ... scheduled to be released on Nov 14., "In ... on the health,of military personnel who have served in ... stress is timely and important," said Marty,Conatser, national commander ...
... Group, Inc.,(OTC Bulletin Board: ANPG), reported today ... the selection of its,disinfectant, EnviroTru(TM) for use ... EnviroTru(TM) is a multi-purpose disinfectant and ... meets EPA requirements for,Toxicity Category IV (no ...
Cached Medicine Technology:American Legion Anticipates Institute of Medicine Report on Gulf War Veterans 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 2Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro) 3
(Date:5/30/2015)... May 30, 2015 Venus Viva has ... scars, large pores, deep wrinkles, stretch marks, pigmentation irregularities, ... professional, such as Dr. F. Victor Rueckl of Lakes ... clinical trials in Las Vegas. This body image solution ... a system that delivers proven results through a skin ...
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a new hanging ... signs ; making what was formerly an elite expensive ... points at a usual height of 16’-20’ are easily seen ... are very unique and more visible than the largest exhibits. ... labor and rigging the costs far outweigh the benefit of ...
(Date:5/29/2015)... MO (PRWEB) May 29, 2015 Based in ... autism awareness shirts for a couple of months ... Their latest release, which reads “I’m not misbehaving, I ... worn by the parent’s of an autistic child in order ... of autism. , Not only are they raising awareness through ...
(Date:5/29/2015)... 2015 What does community do? , ... community comes together to plant gardens, to teach young ... awareness of critical issues. Community invites everyone to help ... , "What Community Does" was commissioned by The Denver ... and released during the foundation’s Annual Celebration in May. ...
(Date:5/29/2015)... M3 USA MDLinx.com, source of the ... specialties, now offers The Smartest Rheumatologist . The ... disorders ranging from Fibromyalgia and Osteoporosis, to Arthritis and ... MDLinx, and Caroline Tredway, editorial head of The Smartest ... have on the physicians who participate. Says Tredway, “With ...
Breaking Medicine News(10 mins):Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:La La Land Shirts Is Busy Spreading Autism Awareness with Complimentary Shipping on Their New Shirt 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:MDLinx Launches Smartest Rheumatologist 2
... testing a candidate 2009 H1N1 influenza vaccine in pregnant ... Allergy and Infectious Diseases (NIAID), part of the National ... higher risk of developing severe illness if they become ... they are strongly encouraged to receive the seasonal influenza ...
... , , , ... Islands announced that the National Science Foundation (NSF) recently honored ... NSF Faculty Early Career Development (CAREER) award. , ... recognition of Gillespie,s teaching and research in protein-ligand interactions and ...
... to staph infections, researchers say , WEDNESDAY, Sept. 9 ... properties, might kill MRSA bacteria. , A new study ... honey, made solely from flowers found on the New ... protein, which is needed for fatty acid biosynthesis. The ...
... Tysabri appears to awaken dormant, common virus that crosses over ... may have discovered part of the reason why Tysabri, a ... development of a rare but potentially deadly brain disease in ... dormant JC virus from its slumber, allowing it to cross ...
... WASHINGTON, Sept. 9 Statement of Lisa A. Rickard, ... reports from White House press secretary Robert Gibbs that President ... Congress: , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080919/USCHAMBERLOGO ... encouraged that President Obama understands the tremendous burden that medical ...
... , , HOFFMAN ESTATES, Ill., Sept. ... open tomorrow, Thursday, Sept. 10, and will continue through October 30, ... 900 Kmart Pharmacy locations for $25 while supplies last. ... your home for family health," says Robbert Ayshford, RPh, divisional vice ...
Cached Medicine News:Health News:NIAID launches 2009 H1N1 influenza vaccine trial in pregnant women 2Health News:CI Faculty Member Awarded Nearly $1 Million NSF Grant 2Health News:MRSA May Succumb to Honey 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 2Health News:Scientists Find Clue to Dangerous Side Effect of MS Drug 3Health News:U.S. Chamber Encourages Obama to Propose Meaningful Medical Liability Reforms in Speech to Congress 2Health News:Kmart Pharmacy Flu Clinics Begin September 10, 2009 2Health News:Kmart Pharmacy Flu Clinics Begin September 10, 2009 3
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... features:Eppendorf "pipette/tip" system ensures utmost accuracy and ...
Medicine Products: